Antitumor activity of monoterpenes found in essential oils

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Sobral, Marianna Vieira ^a   Xavier, Aline Lira ^a   Lima, Tamires Cardoso ^b   De Sousa, Damião Pergentino ^a,b  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOOCIMENE; ALPHA THUJAPLICIN; ASCARIDOLE; BETA DOLABRIN; BETA PINENE; BORNEOL; CAMPHOR; CARVACROL; CARVONE; CINEOLE; CITRAL; CYMENE; ESSENTIAL OIL; GERANIOL; LIMONENE; LINALOOL; MENTHOL; MYRCENE; PERILLIC ACID; PERILLYL ALCOHOL; PINENE; SOBREROL; TERPENE; TERPINEN 4 OL; TERPINEOL; TERPINOLENE; THUJAPLICIN; THYMOHYDROQUINONE; THYMOL; THYMOQUINONE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; EXPERIMENTAL MODEL; HUMAN; NEOPLASM; NONHUMAN; REVIEW; ANIMAL; CHEMISTRY; ISOLATION AND PURIFICATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MONOTERPENES; OILS, VOLATILE; PLANT EXTRACTS;

EID: 84908324531     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/953451     Document Type: Review

References (193)

1. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 10.1016/j.cell.2011.02.013
2. Brasil Ministério da Saúde, Instituto Nacional de Câncer, Políticas e Ações para Prevenção do Câncer no Brasil Alimentação, Nutrição e Atividade Física 2009 Rio de Janeiro, Brazil INCA
3. Pita J. C. L. R., Xavier A. L., de Sousa T. K. G., Mangueira V. M., Tavares J. F., de Oliveira Júnior R. J., Veras R. C., Pessoa H. L. F., Silva M. S., Morelli S., R V. M., Silva T. G., Diniz M. F. F. M., Castello-Branco M. V. S., Oliveira Júnior R. J., Ávila V. M. R., In vitro and in vivo antitumor effect of trachylobane-360, a diterpene from Xylopia langsdorffiana. Molecules 2012 17 8 9573 9589 10.3390/molecules17089573
4. Efferth T., Cancer therapy with natural products and medicinal plants. Planta Medica 2010 76 1035 1036 10.1055/s-0030-1250062
5. De Sousa D. P., Medicinal Essential Oils: Chemical, Pharmacological and Therapeutic Aspects 2012 1st New York, NY, USA Nova Science Publishers
6. Rasoanaivo P., Randriana R. F., Maggi F., Nicolettid M., Quassinti L., Bramuccic M., Lupidic G., Petrellie D., Vitali L. A., Papa F., Vittori S., Chemical composition and biological activities of the essential oil of Athanasia brownie Hochr. (Asteraceae) endemic to Madagascar. Chemistry & Biodiversity 2013 10 10 1876 1886 10.1002/cbdv.201300147
7. Zapata B., Betancur L. G., Duran C., Stashenko E., Cytotoxic activity of Asteraceae and Verbenaceae family essential oils. Journal of Essential Oil Research 2014 6 50 57
8. Piaru S. P., Mahmud R., Majid A. M. S. A., Ismail S., Man C. N., Chemical composition, antioxidant and cytotoxicity activities of the essential oils of Myristica fragrans and Morinda citrifolia. Journal of the Science of Food and Agriculture 2012 92 593 597 10.1002/jsfa.4613
9. Ferraz R. P. C., Bomfim D. S., Carvalho N. C., Soares M. B. P., Silva T. B., Machado W. J., Prata A. P. N., Costa E. V., Moraes V. R. S., Nogueira P. C. L., Bezerra D. P., Bomfim D. S., Cytotoxic effect of leaf essential oil of Lippia gracilis Schauer (Verbenaceae). Phytomedicine 2013 20 615 621
10. Maggi F. F., Randriana R. F., Rasoanaivo P., Nicolettid M., Quassinti L., Bramuccia M., Petrellie G. L. D., Vitali L. A., Papa F., Vittori S., Chemical composition and in vitro biological activities of the essential oil of Vepris macrophylla (BAKER) I.VERD. endemic to Madagascar. Chemistry & Biodiversity 2013 10 3 356 365
11. Nikolić M., Glamočlija J., Ferreira I. C. F. R., Calhelha R. C., Fernandes A., Markovic T., Markovic D., Giwelie A., Sokovic M., Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L., Thymus algeriensis Boiss. and Reut and Thymus vulgaris L. essential oils. Industrial Crops and Products 2014 52 183 190 10.1016/j.indcrop.2013.10.006
12. Deb D. D., Parimala G., Saravana D. S., Chakraborty T., Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chemico-Biological Interactions 2011 193 1 97 106 10.1016/j.cbi.2011.05.009
13. Itani W. S., El-Banna S. H., Hassan S. B., Larsson R. L., Gali-Muhtasib A., U H., Anti-colon cancer components from Lebanese sage (Salvia libanotica) essential oil: mechanistic basis. Cancer Biology & Therapy 2008 7 1765 1773
14. Hayes A. J., Leach D. N., Markham J. L., Markovic B., In vitro cytotoxicity of Australian tea tree oil using human cell lines. Journal of Essential Oil Research 1997 9 575 582 10.1080/10412905.1997.9700780
15. Lampronti I., Saab A. M., Gambari R., Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. International Journal of Oncology 2006 29 989 995
16. Hassan S. B., Gali-Muhtasib H., Goeransson H., Larsson R., Alpha terpineol: a potential anticancer agent which acts through suppressing NF- B signalling. Anticancer Research 2010 30 1911 1919
17. Okamura K., Iwakami S., Matsunaga T., Biological activity of monoterpenes from trees. Toyama-Ken Yakuji Kenkyusho Nenpo 1993 20 95 101
18. Lu H. F., Liu J. Y., Hsueh S. C., Yang Y. Y., Yang J. S., Tan T. W., Kok L. F., Lu C. C., Lan S. H., Wu S. Y., Liao S. S., Ip S. W., Chung J. G., (-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo. In Vivo 2007 21 2 285 289
19. Lin J. P., Lu H. F., Lee J. H., Lin J. G., Hsia T. C., Wu L. T., Chung J. G., Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells. Anticancer Res 2005 25 2069 2074
20. Park E. J., Kim S. H., Kim B. J., Kim S. Y., So I., Jeon J. H., Menthol enhances an antiproliferative activity of 1 α25-dihydroxyvitamin D3 in LNCaP cells. Journal of Clinical Biochemistry and Nutrition 2009 44 2 125 130
21. Wang Y., Wang X., Yang Z., Zhu G., Chen D., Meng Z., Menthol inhibits the proliferation and motility of prostate cancer DU145 cells. Pathology Oncology Research 2005 18 4 903 910
22. Li Q., Wang X., Yang Z., Wang B., Li S., Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24. Oncology 2009 77 6 335 341 10.1159/000264627
23. Okamoto Y., Ohkubo T., Ikebe T., Yamazaki J., Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. International Journal of Oncology 2012 40 1431 1440
24. Matsumura E., Morita Y., Date T., Tsujibo H., Yasuda M., Okabe T., Ishida N., Inamori Y., Cytotoxicity of the hinokitiol-related compounds, γ -thujaplicin and β -dolabrin. Biological & Pharmaceutical Bulletin 2001 24 299 302
25. Morita Y., Matsumura E., Tsujibo H., Yasuda M., Sakagami Y., Okabe T., Ishida N., Inamori Y., Biological activity of a-thujaplicin, the minor component of Thujopsis dolabrata Sieb. et Zucc. var. hondai Makino. Biological & Pharmaceutical Bulletin 2001 24 607 611
26. Slamenova D., Horvathova E., Wsolova L., Sramkova M., Navarova J., Investigation of anti-oxidative, cytotoxic, DNA-damaging and DNA-protective effects of plant volatiles eugenol and borneol in human-derived HepG2, Caco-2 and VH10 cell lines. Mutation Research 2009 677 1-2 46 52
27. Su J., Lai H., Chen J., Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activationof ROS-mediated DNA damage. PLoS ONE 2013 8 e63502
28. Efferth T., Olbrich A., Sauerbrey A., Ross D. D., Gebhart E., Neugebauer M., Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells. Anticancer Research 2002 22 4221 4224
29. Bezerra D. P., Marinho Filho J. D. B., Alves A. P. N. N., Pessoa C., de Moraes M. O., Pessoa O. D. L., Torres M. C. M., Silveira E. R., Viana F. A., Costa-Lotufo L. V., Antitumor activity of the essential oil from the leaves of Croton regelianus and its component ascaridole. Chemistry & Biodiversity 2009 6 1224 1231
30. Gedara S. R., Terpenoid content of the leaves of Thymus algeriensis Boiss. Mansoura Journal of Pharmaceutical Sciences 2008 24 133 143
31. Jaafari A., Ait Mouse H., Rakib E. M., Ait M'barek L., Tilaoui M., Benbakhta C., Boulli A., Abbad A., Zyad A., Chemical composition and antitumor activity of different wild varieties of Moroccan thyme. Revista Brasileira de Farmacognosia 2007 17 477 491
32. Horvathova E., Sramkova M., Labaj J., Slamenovam D., Study of cytotoxic, genotoxic and DNA-protective effects of selected plant essential oils on human cells cultured in vitro. Neuroendocrinology Letters 2006 27 44 47
33. Horvathova E., Turcaniova V., Slamenova D., Comparative study of DNA-damaging and DNA-protective effects of selected components of essential plant oils in human leukemic cells K562. Neoplasma 2007 54 478 483
34. Slamenova D., Horvathova E., Sramkova M., Marsalkova L., DNA-protective effects of two components of essential plant oils carvacrol and thymol on mammalian cells cultured in vitro. Neoplasma 2007 54 108 112
35. Stammati A., Bonsi P., Zucco F., Moezelaar R., Alakomi H.-L., von Wright A., Toxicity of selected plant volatiles in microbial and mammalian short-term assays. Food and Chemical Toxicology 1999 37 8 813 823 10.1016/S0278-6915(99)00075-7
36. Yin Q. H., Yan F. X., Zu X. Y., Wu Y. H., Wu X. P., Liao M. C., Deng S. W., Yin L. L., Zhuang Y. Z., Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 2012 64 43 51 10.1007/s10616-011-9389-y
37. Arunasree K. M., Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 2010 17 8-9 581 588 10.1016/j.phymed.2009.12.008
38. Jayakumar S., Madankumar A., Asokkumar S., Raghunandhakumar S., Gokula dhas K., Kamaraj S., Divya M. G. J., Devaki T., Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry 2012 360 51 60
39. Jaafari A., Mouse H. A., M'Bark L. A., Tilaoui M., Elhansali M., Lepoivre M., Aboufatima R., Melhaoui A., Chait A., Zyad A., Differential antitumor effect of essential oils and their major components of Thymus broussonettii: relationship to cell cycle and apoptosis induction. Herba Polonica Journal 2009 55 36 50
40. Zeytinoglu H., Incesu Z., Baser K. H. C., Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. Phytomedicine 2003 10 292 299
41. Ipek E., Zeytinoglu H., Okay S., Tuylu B. A., Kurkcuoglu M., Baser K. H. C., Genotoxicity and antigenotoxicity of Origanum oil and carvacrol evaluated by Ames Salmonella/microsomal test. Food Chemistry 2005 93 3 551 556 10.1016/j.foodchem.2004.12.034
42. Ozkan A., Erdogan A., A comparative evaluation of antioxidant and anticancer activity of essential oil from Origanum onites (Lamiaceae) and its two major phenolic components. Turkish Journal of Biology 2011 35 735 742
43. Zeytinoglu M., Aydin S., Ozturk Y., Husnu K., Baser C., Inhibitory effects of carvacrol on DMBA induced pulmonary tumorigenesis in rats. Acta Pharmaceutica Turcica 1998 40 2 93 98
44. Hirobe C., Qiao Z. S., Takeya K., Itokawa H., Cytotoxic principles from Majorana syriaca. Nature Medicine 1998 52 74 77
45. Paramasivam A., Sambantham S., Shabnam J., Raghunandhakumar S., Anandan B., Rajiv R., Vijayashree Priyadharsini J., Jayaraman G., Anti-cancer effects of thymoquinone in mouse neuroblastoma (Neuro-2a) cells through caspase-3 activation with down-regulation of XIAP. Toxicology Letters 2012 213 151 159
46. Jaafari A., Tilaoui M., Ait Mouse H. A., Ait M'bark L. A., Aboufatima R., Chait A., Lepoivre M., Zyad A., Comparative study of the antitumor effect of natural monoterpenes: relationship to cell cycle analysis. Revista Brasileira de Farmacognosia 2012 22 534 540
47. Ivankovic S., Stojkovic R., Jukic M., Milos M., Jurin M., The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Experimental Oncology 2006 28 220 224
48. Johnson H. A., Rogers L. L., Alkire M. L., McCloud T. G., McLaughlin J. L., Bioactive monoterpenes from Monarda fistulosa (Lamiaceae). Natural Product Letters 1998 11 4 241 250 10.1080/10575639808044955
49. Rooney S., Ryan M. F., Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Research 2005 25 2199 2204
50. Bourgou S., Pichette A., Marzouk B., Legault J., Bioactivities of black cumin essential oil and its main terpenes from Tunisia. South African Journal of Botany 2010 76 210 216 10.1016/j.sajb.2009.10.009
51. Cecarini V., Quassinti L., di Blasio A., Bonfili L., Bramucci M., Lupidi G., Cuccioloni M., Mozzicafreddo M., Angeletti M., Eleuteri A. M., Effects of thymoquinone on isolated and cellular proteasomes. FEBS Journal 2010 277 2128 2141
52. Jafri S. H., Glass J., Shi R., Zhang S., Prince M., Kleiner-Hancock H., Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. Journal of Experimental & Clinical Cancer Research 2010 29 87
53. Badary O. A., Nagi M. N., al-Shabanah O. A., al-Sawaf H. A., al-Sohaibani M. O., al-Bekairi A. M., Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Canadian Journal of Physiology and Pharmacology 1997 75 1356 1361 10.1139/y97-169
54. Badary O. A., Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. Journal of Ethnopharmacology 1999 67 2 135 142 10.1016/S0378-8741(98)00242-6
55. Banerjee S., Kaseb A. O., Wang Z., Kong D., Mohammad M., Padhye S., Sarkar F. H., Mohammad R. M., Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Research 2009 69 5575 5583 10.1158/0008-5472.CAN-08-4235
56. Sethi G., Ahn K. S., Aggarwal B. B., Targeting nuclear factor- B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research 2008 6 6 1059 1070 10.1158/1541-7786.MCR-07-2088
57. Gali-Muhtasib H., Kuester D., Mawrin C., Bajbouj K., Diestel A., Ocker M., Habold C., Foltzer-Jourdainne C., Schoenfeld P., Peters B., Diab-Assaf M., Pommrich U., Itani W., Lippert H., Roessner A., Schneider-Stock R., Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Research 2008 68 5609 5618 10.1158/0008-5472.CAN-08-0884
58. Li F., Rajendran P., Sethi G., Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. British Journal of Pharmacology 2010 161 3 541 554
59. Badary O. A., El-Din A. M. G., Antitumor activity of thymoquinone against fibrosarcoma tumorigenesis. Cancer Molecular Biology 2000 7 3 1515 1526
60. Badary O. A., Gamal E. A. M., Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detection and Prevention 2001 25 362 368
61. Barron J., Benghuzzi H., Tucci M., Effects of thymoquinone and selenium on the proliferation of MG 63 cells in tissue culture. Biomedical Sciences Instrumentation 2008 44 434 440
62. Roepke M., Diestel A., Bajbouj K., Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biology & Therapy 2007 6 160 169
63. Peng L., Liu A., Shen Y., Xu H. Z., Yang S. Z., Ying X. Z., Liao W., Liu H. X., Lin Z. Q., Chen Q. Yu., Antitumorandanti-angiogenesis effects ofthymoquinoneon osteosarcoma through the NF- κ B pathway. Oncology Reports 2013 29 571 578
64. Yazan L. S., Ng W. K., Al-Naqeeb G., Ismail M., Cytotoxicity of thymoquinone (TQ) from Nigella sativa towards human cervical carcinoma cells (HeLa). Journal of Pharmacy Research 2009 2 585 589
65. El-Najjar N., Chatila M., Moukadem H., Vuorela H., Ocker M., Gandesiri M., Schneider-Stock R., Gali-Muhtasib H., Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 2010 15 183 195 10.1007/s10495-009-0421-z
66. Wilson-Simpson F., Vance S., Benghuzzi H., Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE). Biomedical Sciences Instrumentation 2007 43 378 383
67. Farah N., Benghuzzi H., Tucci M., Cason Z., The effects of isolated antioxidants from black seed on the cellular metabolism of A549 cells. Biomedical Sciences Instrumentation 2005 41 211 216
68. Zubair H., Khan H. Y., Sohail A., Azim S., Ullah M. F., Ahmad A., Sarkar F. H., Hadi S. M., Redox cycling of endogenous copper bythymoquinoneleads to ROS-mediated DNA breakage and consequent cell death: putativeanticancermechanism of antioxidants. Cell Death & Disease 2013 4 e660
69. Talib W. H., Abu Khader M. M., Combinatorial effects ofthymoquinoneon theanticanceractivityand hepatotoxicity of the prodrug CB 1954. Scientia Pharmaceutica 2013 81 519 530 10.3797/scipharm.1211-15
70. Richards L. R., Jones P., Hughes J., Benghuzzi H., Tucci M., LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid. Biomedical Sciences Instrumentation 2007 43 242 247
71. Richards L. R., Jones P., Benghuzzi H., Tucci M., A comparison of the morphological changes associated with conventional and sustained treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on LNCaP cells. Biomedical Sciences Instrumentation 2008 44 465 470
72. El-Mahdy M. A., Zhu Q., Wang Q., Wani G., Wani A. A., Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. International Journal of Cancer 2005 117 409 417
73. Koka P. S., Mondal D., Schultz M., Abdel-Mageed A. B., Agrawal K. C., Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species. Experimental Biology and Medicine 2010 235 751 760
74. Shoieb A. M., Elgayyar M., Dudrick P. S., Bell J. L., Tithof P. K., In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. International Journal of Oncology 2003 22 107 113
75. Hassan S. A., Ahmed W. A., Galeb F. M., El-Taweel M. A., Abu-Bedair F. A., In vitro challenge using thymoquinone on hepatocellular carcinoma (HepG2) cell line. Iranian Journal of Pharmaceutical Research 2008 7 283 290
76. Gali-Muhtasib H. U., Kheir W. G. A., Kheir L. A., Darwiche N., Crooks P. A., Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 2004 15 389 399
77. Gurung R. L., Lim S. N., Khaw A. K., Soon J. F. F., Shenoy K., Ali S. M., Jayapal M., Sethu S., Baskar R., Hande M. P., Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS ONE 2010 5 e12124
78. Satooka H., Kubo I., Effects of thymol on B16-F10 melanoma cells. Journal of Agricultural and Food Chemistry 2012 60 2746 2752
79. Abusnina A., Alhosin M., Keravis T., Muller C. D., Fuhrmann G., Bronner C., Lugnier C., Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis. Cellular Signalling 2011 23 152 160
80. Torres M. P., Ponnusamy M. P., Chakraborty S., Smith L. M., Das S., Arafat H. A., Batra S. K., Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies. Molecular Cancer Therapeutics 2010 9 1419 1431
81. Worthen D. R., Ghosheh O. A., Crooks P. A., The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Research 1998 18 1527 1532
82. el-SA A., Zhu Q., Shah Z. I., Wani G., Barakat B. M., Racoma I., El-Mahdy M. A., Wani A. A., Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutation Research 2011 706 1-2 28 35
83. Ravindran J., Nair H. B., Sung B., Prasad S., Tekmal R. R., Aggarwal B. B., Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochemical Pharmacology 2010 79 11 1640 1647 10.1016/j.bcp.2010.01.023
84. Ganea G. M., Fakayode S. O., Losso J. N., Van Nostrum C. F., Sabliov C. M., Warner I. M., Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles. Nanotechnology 2010 21 28 285104
85. Wirries A., Breyer S., Quint K., Schobert R., Ocker M., Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells. Experimental and Therapeutic Medicine 2010 1 369 375
86. Banerjee S., Azmi A. S., Padhye S., Singh M. W., Baruah J. B., Philip P. A., Sarkar F. H., Mohammad R. M., Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer. Pharmaceutical Research 2010 27 1146 1158 10.1007/s11095-010-0145-3
87. Effenberger K., Breyer S., Schobert R., Terpene conjugates of the Nigella sativa seed-oil constituent thymoquinone with enhanced efficacy in cancer cells. Chemistry & Biodiversity 2010 7 129 139
88. El-Najjar N., Ketola R., A T., Mauriala T., Antopolsky M., Janis J., Gali-Muhtasib H., Urtti A., Vuorela H., Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone. The Journal of Biological Chemistry 2011 4 97 107
89. Al-Shabanah O. A., Badary O. A., Nagi M. N., Al-Gharably N. M., Al-Rikabi A. C., Al-Bekairi A. M., Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. Journal of Experimental & Clinical Cancer Research 1998 17 2 193 198
90. Nagi M. N., Almakki H. A., Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytotherapy Research 2009 23 1295 1298 10.1002/ptr.2766
91. Li Y., Yeung C., Chiu L. C. M., Cen Y., Ooi V. E. C., Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla. Phytotherapy Research 2009 23 1 140 142 10.1002/ptr.2567
92. 1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Life Sciences 2013 93 783 790 10.1016/j.lfs.2013.09.009
93. Effenberger-Neidnicht K., Schobert R., Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemotherapy and Pharmacology 2011 67 867 874
94. Tundis R., Loizzo M. R., Bonesi M., Menichini F., Dodaro D., Passalacqua N. G., Statti G., In vitro cytotoxic effects of Senecio stabianus Lacaita (Asteraceae) on human cancer cell lines. Natural Products Research 2009 23 18 1707 1718
95. Salem M. L., Alenzi F. Q., Attia W. Y., Thymoquinone, the active ingredient of Nigella sativa seeds, enhances survival and activity of antigen-specific CD8-positive T cells in vitro. British Journal of Biomedical Science 2011 68 3 131 137
96. Attoub S., Sperandio O., Raza H., Arafat K., Al-Salam S., Al Sultan M. A., Al Safi M., Takahashi T., Adem A., Thymoquinoneas an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundamental & Clinical Pharmacology 2013 27 557 569
97. Lang M., Borgmann M., Oberhuber G., Evstatiev R., Jimenez K., Dammann K. W., Jambrich M., Khare V., Campregher C., Ristl R., Gasche C., Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling. Molecular Cancer 2013 12 41 10.1186/1476-4598-12-41
98. Abdelfadil E., Cheng Y., Bau D., Ting W., Chen L., Hsu H., Lin Y., Chen R., Tsai F., Tsai C., Thymoquinone induces apoptosis in oral câncer cells through P38 β Inhibition. The American Journal of Chinese Medicine 2013 41 683 696 10.1142/S0192415X1350047X
99. Odeh F., Ismail S. I., Abu-Dahab R., Mahmoud I. S., Al Bawab A., Thymoquinonein liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Delivery 2012 19 371 377 10.3109/10717544.2012.727500
100. Das S., Dey K. K., Dey G., Pal I., Majumder A., Maiti Choudhury S., Kundu S. C., Mandal M., Antineoplasticand apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS ONE 2012 7 e46641 10.1371/journal.pone.0046641
101. Alhosin M., Ibrahim A., Boukhari A., Sharif T., Gies J. P., Auger C., Schini-Kerth V. B., Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts. Investigational New Drugs 2012 30 1813 1819
102. Saleh M. M., Hashem F. A., Glombitza K. W., Cytotoxicity and in vitro effects on human cancer cell lines of volatiles of Apium graveolens var. filicinum. Pharmaceutical & Pharmacological Letters 1998 8 97 99
103. Silva S. L., Figueiredo P. M., Yano T., Cytotoxic evaluation of essential oil from Zanthoxylum rhoifolium Lam. Leaves. Acta Amazonica 2007 37 281 286
104. Elegbede J. A., Maltzman T. H., Elson C. E., Gould M. N., Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis 1993 14 6 1221 1223 10.1093/carcin/14.6.1221
105. Crowell P. L., Ayoubi A. S., Burke Y. D., Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Dietary Phytochemicals in Cancer Prevention and Treatment 1996 401 New York, NY, USA Springer 131 136 Advances in Experimental Medicine and Biology 10.1007/978-1-4613-0399-2-10
106. Sonboli A., Esmaeili M. A., Gholipour A., Kanani M., Composition, cytotoxicity and antioxidant activity of the essential oil of Dracocephalum surmandinum from Iran. Natural Product Communications 2010 5 341 344
107. Gelb M. H., Tamanoi F., Yokoyama K., Ghomashchi F., Esson K., Gould M. N., The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Letters 1995 91 2 169 175 10.1016/0304-3835(95)03747-K
108. Manassero C. A., Girotti J. R., Mijailovsky S., García de Bravo M., Polo M., In vitro comparative analysis of antiproliferative activity of essential oil from mandarin peel and its principal component limonene. Natural Product Research 2013 2 1475 1478
109. Bhattacharjee B., Chatterjee J., Identification of proapoptopic, anti-inflammatory, anti-proliferative, anti-invasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pacific Journal of Cancer Prevention 2013 14 3735 3742
110. Ji J., Zhang L., Wu Y., Zhu X., Lv S., Sun X., Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. Leukemia & Lymphoma 2006 47 2617 2624
111. Kawamori T., Tanaka T., Hirose Y., Ohnishi M., Mori H., Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Carcinogenesis 1996 17 2 369 372
112. Pattanayak M., Seth P. K., Smita S., Gupta S. K., Geraniol and limonene interaction with 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase for their role as cancer chemo-preventive agents. Journal of Proteomics & Bioinformatics 2009 2 466 474 10.4172/jpb.1000107
113. Chen X., Shuzo O., Li Y., Han R., Effect of d-limonene, Salvia miltiorrhiza and turmeric derivatives on membrane association and gap junction intercellular communication of ras gene product. Yao Xue Xue Bao 1998 33 821 827
114. Haag J. D., Lindstrom M. J., Gould M. N., Limonene-induced regression of mammary carcinomas. Cancer Research 1992 52 14 4021 4026
115. Chander S. K., Lansdown A. G. B., Luqmani Y. A., Gomm J. J., Coope R. C., Gould N., Coombes R. C., Effectiveness of combined limonene and 4-hydroxy androstenedione in the treatment of NMU-induced rat mammary tumors. The British Journal of Cancer 1994 69 879 882
116. Elson C. E., Maltzman T. H., Boston J. L., Tanner M. A., Gould M. N., Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 1988 9 331 332
117. Chidambara K. N. M., Jayaprakasha G. K., Shivappa M., Mantur B. S. P., Citrus monoterpenes: potential source of phytochemicals for cancer prevention. Emerging Trends in Dietary Components for Preventing and Combating Disease 2010 545 558
118. Manuele M. G., Ferraro G., Anesini C., Effect of Tilia x viridis flower extract on the proliferation of a lymphoma cell line and on normal murine lymphocytes: contribution of monoterpenes, especially limonene. Phytotherapy Research 2008 22 1520 1526
119. Raphael T. J., Kuttan G., Preliminary study of antimetastatic activity of naturally occurring monoterpene limonene. Amala Research Bulletin 2003 23 99 106
120. Morse M. A., Toburen A. L., Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene. Cancer Letters 1996 104 211 217
121. Elegbede J. A., Gould M. N., Monoterpenes reduced adducts formation in rats exposed to aflatoxin B1. African Journal of Biotechnology 2002 1 46 49
122. Zheng G. Q., Kenney P. M., Lam L. K. T., Potential anticarcinogenic natural products isolated from lemongrass oil and galanga root oil. Journal of Agricultural and Food Chemistry 1993 41 153 156
123. Parija T., Ranjan B., Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by d-limonene. Molecular Biology Reports 2003 30 1 41 46
124. Zheng G. Q., Zhang J., Kenney P. M., Lam L. K. T., Stimulation of glutathione S-transferase and inhibition of carcinogenesis in mice by celery seed oil constituents. ACS Symposium Series 1994 546 230 238
125. Yeruva L., Pierre K. J., Elegbede A., Wang R. C., Carper S. W., Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non-small cell lung cancer cells. Cancer Letters 2007 257 216 226
126. Samaila D., Toy B. J., Wang Robert C., Elegbede A., Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. Anticancer Research 2004 24 5 3089 3095
127. Stark J. M., Burke Y. D., McKinzie J. H., Ayoubi S. A., Crowell P. L., Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Letters 1995 96 1 15 21
128. Burke Y. D., Stark M. J., Roach S. L., Sen S. E., Crowell P. L., Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 1997 32 2 151 156 10.1007/s11745-997-0019-y
129. Stayrook K. R., Mckinzie J. H., Barbhaiya L. H., Crowell P. L., Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells. Anticancer Research 1998 18 823 828
130. Stayrook K. R., Mckinzie J. H., Burke Y. D., Burke Y. A., Crowell P. L., Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 1997 18 1655 1658
131. Lebedeva I. V., Su Z., Vozhilla N., Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis. Molecular Cancer Therapeutics 2008 7 2042 2050
132. Sundin T., Peffley D. M., Gauthier D., Hentosh P., The isoprenoid perillyl alcohol inhibits telomerase activity in prostate câncer cells. Biochimie 2012 94 2639 2648
133. Chen Y., Hu D., Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 2004 24 41 44
134. Clark S. S., Perillyl alcohol Iinduces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells. Oncology 2006 70 13 18
135. Loutrari H., Hatziapostolou M., Skouridou V., Papadimitriou E., Roussos C., Kolisis F. N., Papapetropoulos A., Perillyl alcohol is an angiogenesis inhibitor. Journal of Pharmacology and Experimental Therapeutics 2004 311 568 575 10.1124/jpet.104.070516
136. Loutrari H., Skouridou V., Kolisis F. N., Roussos C., Papapetropoulos A., Perillyl alcohol attenuates in vitro angiogenesis, modulates angiogenic factor production and inhibits cell proliferation and survival in endothelial and tumour cells. Epitheorese Klinikes Farmakologias kai Farmakokinetikes 2004 18 30 32
137. Garcia D. G., Amorim L. M. F., Castro F. M. V., Freire A. S., Santelli R. E., da Fonseca C. O., Santos T. Q., Burth P., The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor. Molecular and Cellular Biochemistry 2010 345 29 34
138. Crowell P. L., Ren Z., Lin S., Vedejs E., Gould M. N., Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochemical Pharmacology 1994 47 1405 1415 10.1016/0006-2952(94)90341-7
139. Sahin M. B., Perman S. M., Jenkins G., Clark S. S., Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines. Leukemia 1999 13 1581 1591
140. Satomi Y., Miyamoto S., Gould M. N., Induction of AP-1 activity by perillyl alcohol in breast cancer cells. Carcinogenesis 1999 20 1957 1961
141. Ahn J. K., Lee C. K., Choi E. K., Griffin R., Song C. W., Park H. J., Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia. International Journal of Radiation Oncology, Biology, Physics 2003 57 813 819
142. Ren Z., Gould M. N., Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Letters 1994 76 185 190
143. Ren Z., Elson C. E., Gould M. N., Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. Biochemical Pharmacology 1997 54 113 120
144. Balassiano I. T., de Paulo S. A., Silva N. H., Cabral M. C., Gibaldi D., Bozza M., da Fonseca C. O., Carvalho M. G. C., Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane. International Journal of Molecular Medicine 2002 10 6 785 788
145. Da Fonseca C. O., Schwartsmann G., Fischer J., Nagel J., Futuro D., Quirico T. S., Gattass C. R., Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surgical Neurology 2008 70 259 267
146. Chaudhary S. C., Alam M. S., Siddiqui M. S., Athar M., Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. Chemico-Biological Interactions 2009 179 145 153
147. Ariazi E. A., Satomi Y., Ellis M. J., Haag J. D., Shi W., Sattler C. A., Gould M. N., Activation of the transforming growth factor β signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Research 1999 59 1917 1928
148. Clark S. S., Perman S. M., Sahin M. B., Jenkins G. J., Elegbede J. A., Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. Leukemia 2002 16 213 222 10.1038/sj.leu.2402369
149. Lebedeva I. V., Su Z., Vozhilla N., Chatman L., Sarkar D., Dent P., Athar M., Fisher P. B., Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol. Cancer Research 2008 68 7439 7447
150. Boon P. J. M., van der Boon D., Mulder G. J., Cytotoxicity and biotransformation of the anticancer drug perillyl alcohol in PC12 cells and in the rat. Toxicology and Applied Pharmacology 2000 167 55 62
151. Phillips L. R., Malspeis L., Supko J. G., Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. Drug Metabolism and Disposition 1995 23 7 676 680
152. Rajesh D., Stenzel R. A., Howard S. P., Perillyl alcohol as a radio-/chemosensitizer in malignant glioma. The Journal of Biological Chemistry 2003 278 35968 35978
153. Ripple G. H., Gould M. N., Stewart J. A., Tutsch K. D., Arzoomanian R. Z., Alberti D., Feierabend C., Pomplun M., Wilding G., Bailey H. H., Phase I clinical trial of perillyl alcohol administered daily. Clinical Cancer Research 1998 4 1159 1164
154. Ripple G. H., Gould M. N., Arzoomanian R. Z., Alberti D., Feierabend C., Simon K., Binger K., Tutsch K. D., Pomplun M., Wahamaki A., Marnocha Wilding R., Bailey G., H H., Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clinical Cancer Research 2000 6 390 396
155. Azzoli C. G., Miller V. A., Kenneth K. N. G., Krug L. M., Spriggs D. R., Tong W. P., Riedel E. R., Kris M. G., A phase I trial of perillyl alcohol in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology 2003 51 493 498
156. Hudes G. R., Szarka C. E., Adams A., Ranganathan S., McCauley R. A., Weiner L. M., Langer C. J., Litwin S., Yeslow G., Halberr T., Qian M., Gallo J. M., Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clinical Cancer Research 2000 6 3071 3080
157. Meadows S. M., Mulkerin D., Berlin J., Bailey H., Kolesar J., Warren D., Thomas J. P., Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. International Journal of Gastrointestinal Cancer 2002 32 2-3 125 128 10.1385/IJGC:32:2-3:125
158. Wang W., Li N., Luo M., Zu Y., Efferth T., Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules 2012 17 3 2704 2713
159. Asanova Z. K., Suleimenov E. M., Atazhanova G. A., Dembitskii A. D., Pak R. N., Dar A., Adekenov S. M., Biological activity of 1,8-cineole from levant wormwood. Pharmaceutical Chemistry Journal 2003 37 28 30
160. Cha J., Kim Y., Kim J., Essential oil and 1, 8-cineole from Artemisia lavandulaefolia induces apoptosis in KB cells via mitochondrial stress and caspase activation. Food Science and Biotechnology 2010 19 185 191
161. Calcabrini A., Stringaro A., Toccacieli L., Meschini S., Marra M., Colone M., Salvatore G., Mondello F., Arancia G., Molinari A., Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. Journal of Investigative Dermatology 2004 122 349 360 10.1046/j.0022-202X.2004.22236.x
162. Bozzuto G., Colone M., Toccacieli L., Stringaro A., Molinari A., Tea tree oil might combat melanoma. Planta Medica 2011 77 54 56
163. Greay S. J., Ireland D. J., Kissick H. T., Levy A., Beilharz M. W., Riley T. V., Carson C. F., Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemotherapy and Pharmacology 2010 65 877 888
164. Dubey N. K., Takeya K., Itokawa H., Citral: a cytotoxic principle isolated from the essential oil of Cymbopogon citratus against P388 leukemia cells. Current Science 1997 73 22 24
165. Wright B. S., Bansal A., Moriarity D. M., Takaku S., Setzer W. N., Cytotoxic leaf essential oils from neotropical Lauraceae: synergistic effects of essential oil components. Natural Product Communications 2007 22 1241 1244
166. Liu Y., Whelan R. J., Pattnaik B. R., Ludwig K., Subudhi E., Rowland H., Claussen N., Zucker N., Uppal S., Kushner D. M., Terpenoids from Zingiber officinale (ginger) induce apoptosis in endometrial cancercells through the activationof p53. PLoS ONE 2012 7 12 e53178 10.1371/journal.pone.0053178
167. Xia H., Liang W., Song Q., Chen X., Chen X., Hong J., The in vitro study of apoptosis in NB4 cell induced by citral. Cytotechnology 2013 65 49 57
168. Mesa-Arango A., Monteil-Ramos J., Zapata B., Duran C., Betancur-Galvis L., Stashenko E., Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E., Brown, composition, cytotoxicity and antifungal activity. Memórias do Instituto Oswaldo Cruz 2009 104 878 884
169. Aydin E., Turkez H., Kele M. S., Potential anticancer activity of carvone in N2a neuroblastoma cell line. Toxicology and Industrial Health 2013
170. Chaverri C., Diaz C., Ciccio J. F., Leaf essential oil of Manekia naranjoana (Piperaceae) from Costa Rica and its cytotoxic activity. Natural Product Communications 2011 6 145 148
171. Bansal A., Moriarity D. M., Takaku S., Setzer W. N., Chemical composition and cytotoxic activity of the leaf essential oil of Ocotea tonduzii from Monteverde, Costa Rica. Natural Product Communications 2007 2 781 784
172. Fraternale D., Ricci D., Calcabrini C., Guescini M., Martinelli C., Sestili P., Cytotoxic activity of essential oils of aerial parts and ripe fruits of Echinophora spinosa (Apiaceae). Natural Product Communications 2013 8 1645 1649
173. Cole R. A., Bansal A., Moriarity D. M., Haber W. A., Setzer W. N., Chemical composition and cytotoxic activity of the leaf essential oil of Eugenia zuchowskiae from Monteverde, Costa Rica. Journal of Natural Medicines 2007 61 414 417
174. Jin K., Bak M., Jun M., Lim H., Jo W., Jeong W. S., α -pinene triggers oxidative stress and related signaling pathways in A549 and HepG2 cells. Food Science and Biotechnology 2010 19 1325 1332
175. Carnesecchi S., Langley K., Exinger F., Gosse F., Raul F., Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment. Journal of Pharmacology and Experimental Therapeutics 2002 301 2 625 630
176. Carnesecchi S., Bras-Goncalves R., Bradaia A., Zeisel M., Gosse F., Poupon M., Raul F., Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Letters 2004 215 1 53 59
177. Polo M. P., de Bravo M. G., Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochemistry and Cell Biology 2006 84 102 111
178. Crespo R., Villegas S. M., Abba M. C., de Bravo M. G., Polo M. P., Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways. Biochemistry and Cell Biology 2013 91 131 139
179. Carnesecchi S., Schneider Y., Ceraline J., Duranton B., Gosse F., Seiler N., Raul F., Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. Journal of Pharmacology and Experimental Therapeutics 2001 298 197 200
180. Ong T. P., Heidor R., de Conti A., Dagli M. L. Z., Moreno F. S., Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 2006 27 1194 1203
181. Cardozo M. T., de Conti A., Ong T. P., Scolastici C., Purgatto E., Horst M. A., Bassoli B. K., Moreno F. S., Chemopreventive effects of β -ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. The Journal of Nutritional Biochemistry 2011 22 130 135 10.1016/j.jnutbio.2009.12.007
182. Madankumar A., Jayakumar S., Gokuladhas K., Rajan B., Raghunandhakumar S., Asokkumar S., Devaki T., Geraniol modulates tongue and hepatic phase I and phase II conjugation activities and may contribute directly to the chemopreventive activity against experimental oral carcinogenesis. European Journal of Pharmacology 2013 705 148 155
183. Wattenberg L. W., Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene (nerolidol). Carcinogenesis 1991 12 151 152
184. Cherng J. M., Shieh D. E., Chiang W., Chang M. Y., Chiang L. C., Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Bioscience, Biotechnology, and Biochemistry 2007 71 1500 1504 10.1271/bbb.70008
185. Chiang L. C., Chiang W., Chang M. Y., Ng L. T., Lin C. C., Antileukemic activity of selected natural products in Taiwan. American Journal of Chinese Medicine 2003 31 37 46
186. Loizzo M. R., Tundis R., Menichini F., Saab A. M., Statti G. A., Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells. Cell Proliferation 2008 41 1002 1012
187. Usta J., Kreydiyyeh S., Knio K., Barnabe P., Bou-Moughlabay Y., Dagher S., Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels. Chemico-Biological Interactions 2009 180 39 46
188. Gu Y., Tinga Z., Qiua X., Zhanga X., Ganc X., Fang Y., Xua X., Xu R., Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology 2010 268 19 24
189. Ravizza R., Gariboldi M. B., Molteni R., Monti E., Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. Oncology Reports 2008 20 625 630
190. Maeda H., Yamazaki M., Katagata Y. K., Kuromoji (Lindera umbellata) essential oil-induced apoptosis and differentiation in human leukemia HL-60 cells. Experimental and Therapeutic Medicine 2012 3 1 49 52
191. Miyashita M., Sadzuka Y., Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity. Food and Chemical Toxicology 2013 53 174 179
192. Afoulous S., Ferhout H., Raoelison E. G., Valentin A., Moukarzel B., Couderc F., Bouajila J., Helichrysum gymnocephalum essential oil: chemical composition and cytotoxic, antimalarial and antioxidant activities, attribution of the activity origin by correlations. Molecules 2011 16 8273 8291 10.3390/molecules16108273
193. Woo C. C., Loo S. Y., Gee V., Yap C. W., Sethi G., Kumar A. P., Tan K. H. B., Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR- γ pathway. Biochemical Pharmacology 2011 82 5 464 475 10.1016/j.bcp.2011.05.030